BioSpace News Archive

A novel cancer therapy studied and developed at the Medical College of Wisconsin (MCW) with promising clinical outcomes is leading to a larger phase II trial to improve on the current standard of care. R

Independent Data Monitoring Committee (IDMC) conducted a pre-planned interim analysis of the Company’s Phase III Comfort™ trial of Piclidenoson for the treatment of psoriasis and recommended to continue with this psoriasis study A separate IDMC for the pre-planned interim analysis of the Acrobat™ Rheumatoid Arthritis (RA) Phase III study recommended not to continue this study. The Company plans to undertake a detailed analysis of the data of the

Aegle Therapeutics Corporation , a first-in-class biotechnology company committed to delivering cell-free therapy to patients affected by severe dermatological conditions, today announced that the FDA has granted Rare Pediatric Disease (RPD) Designation to AGLE-102™ for the treatment of dystrophic epidermolysis bullosa (DEB),

GT Biopharma, Inc. (OTCQB:GTBP) announced today that it had entered into a partnership agreement with Cytovance Biologics, a USA-based contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (“Hepalink”).

Nurix Therapeutics, Inc., (NASDAQ: NRIX), a company developing targeted protein modulation drugs, today announced the Company will be presenting at the 3rd Targeted Protein Degradation (TPD) Summit held virtually.

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced that it has expanded its pivotal Phase 3 REVERSE-IT trial for its lead product candidate bentracimab

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation for TK216,

MedShape, Inc., the industry leader in orthopedic devices using advanced functional materials, today announced the U.S. Centers for Medicare & Medicaid Services (CMS) has issued a new ICD-10-PCS code for a sustained compression internal fixation device in both lower and upper extremity joint fusion procedures

Lygos, Inc., a vertically integrated provider of sustainable specialty ingredients that deliver high-value performance without environmental toxicity, announced today that it has partnered with Open Book Extracts, Inc. (OBX), a cannabinoid-enabled health and wellness company, to develop nutraceutical supplement products featuring Lygos-produced cannabigerol (CBG).

The Industry-Leading Engagement and Digital Communication Solutions from EnlivenHealth Aim to Achieve Lifelong Optimal Health for Patient Populations MOUNTAIN VIEW, Calif.--( BUSINESS WIRE )-- Omnicell, Inc., (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it is launching EnlivenHealth™, a division dedicated to enabling retail pharmacies and health plans t